2015 Food & Drug Conference Speakers

Presented in order of appearance.

Martin HMartin Hahn
Hogan Lovells US LLP
GMO Foods: Fact, Fiction and Future

Martin is a partner in the Washington, D.C. office of Hogan Lovells US LLP and is a member of the firm’s Food and Agriculture Practice Group.  His practice focuses on a wide variety of regulatory issues affecting the food, dietary supplement and functional food industries. He assists companies and trade associations in complying with the requirements of the U.S. Food and Drug Administration (FDA), the Food Safety and Inspection Service (FSIS) of the United States Department of Agriculture (USDA), and the Federal Trade Commission.


Paul W

Paul L. Whiteley, Jr.
UFCW Local 227
UFCW Distilleries: Insight and Update

With a background in social work and community empowerment, Paul Whiteley has dedicated his career to helping hard-working men and women come together for a better life. Paul joined UFCW Local 227 as an organizer in 1999. Later, he served as Collective Bargaining Director and was sworn in as Secretary-Treasurer in January 2015.


Matt TMatt Tenney
Author
Serve to be Great: Leadership Lessons from
a Prison, a Monastery and a Boardroom

Matt is a social entrepreneur and the author of Serve to be Great: Leadership Lessons from a Prison, a Monastery and a Boardroom. He has traveled internationally as a keynote speaker, trainer and consultant with the prestigious Perth Leadership Institute. He works with companies, associations, universities and non-profits to develop highly effective leaders who can achieve lasting success by focusing on serving and inspiring greatness in the people around them. Matt envisions a world where the majority of people realize effectively serving others is the key to true greatness.


Ian RIan Ruskin
Actor/Playwright
To Make a Long Story Short:
The Life and Times of Sam Kagel

Ian is a graduate of the Royal Academy of Dramatic Arts in London. He founded The Harry Bridges Project in 2000 and has performed the play From Wharf Rats to Lords of the Docks, based on the labor leader’s life, to more than 50,000 people. His other play, To Begin the World Over Again: The Life of Thomas Paine, continues his mission to present the stories of misunderstood heroes from American and European history. The play was filmed and will be distributed to public television stations in 2016.


Joe SJoe Sweeney
The Segal Co.
The Cadillac Tax: What Was the Point
and Can We Steer Clear of It?

Joe is Senior Vice President of The Segal Company’s San Francisco office. He joined the company in 1994. Since then, he has been actively involved in a variety of benefit strategy projects with a focus on multi-employer health care and pension projects, including assessment of current benefit programs, development of program strategies, and implementing and developing price and contribution strategies based on clients’ costs and benefit objectives.


Mark BMark Blum
America’s Agenda: Health Care For All
Pharmaceutical Drugs:
Why Are Prices So High in the United States?

Mark is executive director of America’s Agenda: Health Care For All, an organization with an unrivaled record of success promoting comprehensive health care reform on the state level. Since enactment of federal health reform, America’s Agenda has worked intensively with international and local unions and union employers to achieve innovative and fundamental transformations of health care delivery for participants of Taft-Hartley health plans in ways that are producing significant reductions in cost while driving continuous improvements in health outcomes.


Gregg HGregg Hymowitz
EnTrust Capital
Pharmaceutical Drugs:
Why Are Prices So High in the United States?

Gregg is the founder and managing partner of EnTrust Capital, as well as chair of EnTrust’s Investment Committee and a member of EnTrust Securities LLC. Prior to founding EnTrust Capital, he was a vice president at Goldman, Sachs & Co., which he joined in 1992. Gregg graduated cum laude from Harvard Law School with a juris doctorate in 1990.


Kyle BKyle Bass
Hayman Capital Management L.P.
Pharmaceutical Drugs:
Why Are Prices So High in the United States?

Kyle is principal of Hayman Capital Management L.P. Hayman serves as the investment manager to private funds focused on global event-driven opportunities, including funds focused specifically on Japan and the pharmaceutical industry. Previously, Kyle co-managed private funds with strategies focused on sub-prime credit.